Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/first-patient-dosed-in-starstruck-study-of-tlx250-targeted-radiation-therapy-in-combination-with-merck-investigational-dna-pk-inhibitor-peposertib-301879251.html

PR NEWSWIRE
18 Jul 2023